Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000185947 | SCV001737831 | benign | not specified | 2021-05-20 | criteria provided, single submitter | clinical testing | Variant summary: HLCS c.*7_*9delGCG is located in the untranslated mRNA region downstream of the termination codon. The variant allele was found at a frequency of 0.0086 in 249008 control chromosomes in the gnomAD database, including 17 homozygotes. The observed variant frequency is approximately 3-fold of the estimated maximal expected allele frequency for a pathogenic variant in HLCS causing Holocarboxylase Synthetase Deficiency phenotype (0.0028), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.*7_*9delGCG in individuals affected with Holocarboxylase Synthetase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. A ClinVar submitter (evaluation after 2014) cites the variant as benign. Based on the evidence outlined above, the variant was classified as benign. |
Gene |
RCV001675661 | SCV001892825 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001675661 | SCV002544669 | benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | HLCS: BS1, BS2 |
Gene |
RCV000185947 | SCV000238904 | benign | not specified | 2014-04-02 | flagged submission | clinical testing | The variant is found in MITONUC-MITOP panel(s). |
Natera, |
RCV001273642 | SCV001456934 | benign | Holocarboxylase synthetase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |